Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

February 5, 2013

 

 

DOLBY LABORATORIES, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-32431   90-0199783

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

100 Potrero Avenue

San Francisco, CA 94103-4813

(Address of principal executive offices) (Zip Code)

(415) 558-0200

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

5.02(e)

At the Dolby Laboratories, Inc. (the “Company”) 2013 Annual Meeting of Stockholders (the “Annual Meeting”), held on February 5, 2013, at the Company’s administrative offices located at 999 Brannan Street, San Francisco, California, 94103, the Company’s stockholders approved an amendment and restatement of the Company’s 2005 Stock Plan and an amendment and restatement of the Company’s Employee Stock Purchase Plan.

The terms and conditions of the Company’s 2005 Stock Plan and Employee Stock Purchase Plan are described in the Company’s Proxy Statement for the Annual Meeting, filed with the Securities and Exchange Commission on December 26, 2012. The Company’s executive officers are eligible to participate in the 2005 Stock Plan and Employee Stock Purchase Plan. The 2005 Stock Plan and Employee Stock Purchase Plan are filed as Exhibit 10.1 and Exhibit 10.2 hereto, respectively, and are incorporated by reference herein.

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

5.07(a) and (b)

The information set forth in Item 5.02(e) above is incorporated by reference herein. At the Annual Meeting, the Company’s stockholders:

 

  1. Elected nine directors to serve until the 2014 Annual Meeting of Stockholders or until their successors are duly elected and qualified;

 

  2. Approved an amendment and restatement of the Company’s 2005 Stock Plan;

 

  3. Approved an amendment and restatement of the Company’s Employee Stock Purchase Plan;

 

  4. Approved an advisory vote to approve the compensation of the Company’s named executive officers;

 

  5. Approved, on an advisory basis, one year as the frequency for holding future advisory votes to approve the compensation of the Company’s named executive officers; and

 

  6. Ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending September 27, 2013.

Each share of the Company’s Class A common stock is entitled to one vote, and each share of the Company’s Class B common stock is entitled to ten votes, on all matters submitted to a vote of stockholders at the Annual Meeting. The Class A common stock and Class B common stock vote together as a single class on all matters submitted to a vote of stockholders at the Annual Meeting. At the Annual Meeting, the holders of Class A common stock and Class B common stock voted as follows:

Proposal 1 – Election of directors:

 

Director

   Votes For    Votes Withheld    Broker Non-Votes

Peter Gotcher

   595,524,632    2,698,336    5,700,932

Micheline Chau

   597,851,732    371,236    5,700,932

David Dolby

   593,448,307    4,774,661    5,700,932

Nicholas Donatiello, Jr.

   596,978,227    1,244,741    5,700,932

Bill Jasper

   595,755,979    2,466,989    5,700,932

Sanford Robertson

   595,580,079    2,642,889    5,700,932

Roger Siboni

   596,640,771    1,582,197    5,700,932

Avadis Tevanian, Jr.

   596,981,431    1,241,537    5,700,932

Kevin Yeaman

   597,830,423    392,545    5,700,932

All director nominees were duly elected.


Proposal 2 – Approval of an amendment and restatement of the Company’s 2005 Stock Plan:

 

Votes For

  Votes Against     Abstentions     Broker Non-Votes  
580,911,114     17,283,135        28,719        5,700,932   

Proposal 2 was approved.

Proposal 3 – Approval of an amendment and restatement of the Company’s Employee Stock Purchase Plan:

 

Votes For

  Votes Against     Abstentions     Broker Non-Votes  
597,870,618     328,256        24,094        5,700,932   

Proposal 3 was approved.

Proposal 4 – Approval of an advisory vote to approve the compensation of the Company’s named executive officers:

 

Votes For

  Votes Against     Abstentions     Broker Non-Votes  
580,124,394     18,020,719        77,855        5,700,932   

Proposal 4 was approved.

Proposal 5 – Approval of an advisory vote on the frequency of holding future advisory votes to approve the compensation of the Company’s named executive officers:

 

1 Year

  2 Years     3 Years     Abstain     Broker Non-Votes  
597,799,193     170,273        228,184        25,318        5,700,932   

A frequency of one year was approved.

Proposal 6 – Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending September 27, 2013:

 

Votes For

  Votes Against     Abstentions  
603,564,387     121,361        238,152   

Proposal 6 was approved.

5.07(d)

In accordance with the recommendation of the Board of Directors, the Company’s stockholders approved, on an advisory basis, one year as the frequency for holding future advisory votes to approve the compensation of the Company’s named executive officers. In light of such approval, the Company intends to hold an advisory vote on the compensation of the Company’s named executive officers on an annual basis until the next required vote on the frequency of holding an advisory vote to approve named executive officer compensation.

Section 9 – Financial Statements and Exhibits

ITEM 9.01 Financial Statements and Exhibits.

(d) Exhibits.


Exhibit
No.

  

Description

10.1    Dolby Laboratories, Inc. 2005 Stock Plan (as amended and restated on February 5, 2013)
10.2    Dolby Laboratories, Inc. Employee Stock Purchase Plan (as amended and restated on February 5, 2013)


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

DOLBY LABORATORIES, INC.
By:  

/s/ Andy Sherman

  Andy Sherman
  Executive Vice President, General Counsel and Secretary

Date: February 11, 2013


EXHIBIT INDEX

 

Exhibit
No.

  

Description

10.1    Dolby Laboratories, Inc. 2005 Stock Plan (as amended and restated on February 5, 2013)
10.2    Dolby Laboratories, Inc. Employee Stock Purchase Plan (as amended and restated on February 5, 2013)